99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice
Journal of Labelled Compounds and Radiopharmaceuticals · 2016-11 · 59 (13) · 582-588
DOI: 10.1002/jlcr.3468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 26.10.2016. Verfasst von Mostafa Erfani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
In the present study paclitaxel (taxol) was labeled with [ 99m Tc(CO) 3 (H 2 O) 3 ] + core. Labeling was optimized, and radiochemical analysis was determined by thin layer chromatography and high performance liquid chromatography. Radiocomplex was evaluated and verified further as a tumor characterization agent in B16‐F10 melanoma tumor‐bearing mice. The [ 99m Tc(CO) 3 (H 2 O) 3 ] + ‐paclitaxel complex with high specific activity (0.77 GBq/μmol) and labeling yield (96.8 ± 1.3) was obtained. No decrease in labeling was observed up to 6 hours, and the stability of the radiocomplex was found adequate. Our main achievement was high accumulation of radiolabeled paclitaxel in tumor (4.51 ± 0.65 percentage injected dose per gram [%ID/g] at 2‐h postinjection) followed by significant reduction (1.86 ± 0.27%ID/g) at 4‐hour postinjection. Because paclitaxel is a substrate for multidrug resistance, 99m Tc‐tricarbonyl‐paclitaxel imaging would be useful for tumor characterization rather than tumor detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.
- Faculty of Nuclear engineering and Physics, Amirkabir University of Technology, Tehran, Iran.
Zitieren
APA
Erfani, M., Shabani, Z., Shamsaei, M., Shirmardi, S. P., & Shafiei, M. (2016). 99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice. Journal of Labelled Compounds and Radiopharmaceuticals, 59(13), 582-588. https://doi.org/10.1002/jlcr.3468
Vancouver
Erfani M, Shabani Z, Shamsaei M, Shirmardi SP, Shafiei M. 99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice. Journal of Labelled Compounds and Radiopharmaceuticals. 2016;59(13):582-588. doi:10.1002/jlcr.3468
BibTeX
@article{Erfani2016,
author = {Erfani, Mostafa and Shabani, Zahra and Shamsaei, Mojtaba and Shirmardi, Seyed Pezhman and Shafiei, Mohammad},
title = {99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2016},
volume = {59},
number = {13},
pages = {582--588},
doi = {10.1002/jlcr.3468}
}
EUVIMED